BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8623260)

  • 21. Porcine endothelial cell antigens recognized by human natural antibodies.
    Platt JL; Holzknecht ZE; Lindman BJ
    Transplant Proc; 1994 Jun; 26(3):1387. PubMed ID: 8029951
    [No Abstract]   [Full Text] [Related]  

  • 22. Porcine islet cell antigens are recognized by xenoreactive natural human antibodies of both IgG and IgM subtypes.
    Korbutt GS; Aspeslet L; Ao Z; Warnock GL; Ezekowitz J; Koshal A; Rajotte RV; Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):837-8. PubMed ID: 8623426
    [No Abstract]   [Full Text] [Related]  

  • 23. Two genetic approaches to the galactose alpha 1,3 galactose xenoantigen.
    d'Apice AJ; Tange MJ; Chen GC; Cowan PJ; Shinkel TA; Pearse MJ
    Transplant Proc; 1996 Apr; 28(2):540. PubMed ID: 8623255
    [No Abstract]   [Full Text] [Related]  

  • 24. Variation in expression of porcine antigens recognized by human xenoreactive natural antibodies.
    Cotterell AH; Alvarado CG; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):278-9. PubMed ID: 7879002
    [No Abstract]   [Full Text] [Related]  

  • 25. Variation in expression of biologically reactive xenoantigen does not correlate with expression of Gal alpha (1-3)Gal.
    Alvarado CG; Cotterell AH; Parker W; Logan JS; Platt JL
    Transplant Proc; 1996 Apr; 28(2):555. PubMed ID: 8623266
    [No Abstract]   [Full Text] [Related]  

  • 26. Human anti-B alloantibodies recognize xenoantigens on pig red blood cells and endothelial cells.
    Gautreau C; Woimant G; Grosse H; Cardoso J; Soubrane O; Houssin D
    Transplant Proc; 1996 Apr; 28(2):563. PubMed ID: 8623273
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
    Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
    Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Converting alpha-Gal epitope of pig into H antigen.
    Koike C; Hayashi S; Yokoyama I; Yamakawa H; Negita M; Takagi H
    Transplant Proc; 1996 Apr; 28(2):553. PubMed ID: 8623264
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of alpha 1,3-galactosyltransferase knockout mice.
    Tange M; Tearle R; Katerelos M; Crawford R; Robins A; Shinkel T; Pearse M; d'Apice AJ
    Transplant Proc; 1996 Apr; 28(2):620-1. PubMed ID: 8623306
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical potential of xenotransplantation.
    Cooper DK; Koren E; Oriol R
    Transplant Proc; 1994 Jun; 26(3):1331-2. PubMed ID: 7518129
    [No Abstract]   [Full Text] [Related]  

  • 31. Human xenoreactive natural antibodies--avidity and targets on porcine endothelial cells.
    Vanhove B; Bach FH
    Transplantation; 1993 Nov; 56(5):1251-3. PubMed ID: 8249132
    [No Abstract]   [Full Text] [Related]  

  • 32. Removal of anti-Gal alpha (1,3)Gal antibodies diminishes the cytotoxic effect of primate xenoreactive antibodies on rat endothelial cells.
    Azimzadeh A; Anegon I; Thibaudeau K; Charreau B; Zibolt P; Cinqualbre J; Soulillou JP; Wolf P
    Transplant Proc; 1997 Aug; 29(5):2337. PubMed ID: 9270751
    [No Abstract]   [Full Text] [Related]  

  • 33. Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies.
    Parker W; Lundberg-Swanson K; Holzknecht ZE; Lateef J; Washburn SA; Braedehoeft SJ; Platt JL
    Hum Immunol; 1996 Feb; 45(2):94-104. PubMed ID: 8882406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to overcome hyperacute rejection of pig-to-human xenografts.
    McKenzie IF; Osman N; Cohney S; Sandrin MS
    Transplant Proc; 1997; 29(1-2):973-4. PubMed ID: 9123613
    [No Abstract]   [Full Text] [Related]  

  • 35. Specificity of preformed natural antibodies directed against living cultured endothelial cells.
    Hammer C; Suckfüll M; Csapo C; Höbel G
    Transplant Proc; 1994 Apr; 26(2):1031-3. PubMed ID: 8171458
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival.
    Lussow AR; Fanget L; Gao L; Buelow R; Pouletty P
    Transplant Proc; 1996 Apr; 28(2):571-2. PubMed ID: 8623277
    [No Abstract]   [Full Text] [Related]  

  • 37. Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies.
    Milland J; Yuriev E; Xing PX; McKenzie IF; Ramsland PA; Sandrin MS
    Immunol Cell Biol; 2007; 85(8):623-32. PubMed ID: 17724458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of Hanganutziu-Deicher antigens in pig-to-human xenotransplantation.
    Kobayashi T; Suzuki A; Yokoyama I; Abe M; Hayashi S; Nagasaka T; Namii Y; Kato T; Tokoro T; Liu D; Nakao A; Matsuda H; Morozumi K; Breimer ME; Rydberg L; Groth CG; Tibell A; Korsgren O; Takagi H
    Transplant Proc; 2000 Aug; 32(5):874. PubMed ID: 10936253
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-pig antibody adsorption efficacy of {alpha}-Gal carrying recombinant P-selectin glycoprotein ligand-1/immunoglobulin chimeras increases with core 2 {beta}1, 6-N-acetylglucosaminyltransferase expression.
    Liu J; Gustafsson A; Breimer ME; Kussak A; Holgersson J
    Glycobiology; 2005 Jun; 15(6):571-83. PubMed ID: 15625182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic removal from various tissues of the galactose alpha 1,3-galactose target antigens of human antispecies antibodies.
    Cairns T; Hammelmann W; Gray D; Welsh K; Larson G
    Transplant Proc; 1994 Jun; 26(3):1279-80. PubMed ID: 7518125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.